scholarly journals Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer

Author(s):  
Yipeng Wang ◽  
Liping Guo ◽  
Lin Feng ◽  
Wen Zhang ◽  
Ting Xiao ◽  
...  
2020 ◽  
Vol 31 ◽  
pp. S1116
Author(s):  
O. Savelieva ◽  
L.A. Tashireva ◽  
E.S. Grigoryeva ◽  
N.A. Tarabanovskaya ◽  
V.M. Perelmuter

2021 ◽  
Vol 32 ◽  
pp. S31
Author(s):  
M.A. Papadaki ◽  
C.A. Apostolopoulou ◽  
A. Monastirioti ◽  
D. Aggouraki ◽  
C. Papadaki ◽  
...  

The Breast ◽  
2014 ◽  
Vol 23 (5) ◽  
pp. 552-560 ◽  
Author(s):  
J. Castle ◽  
H. Shaker ◽  
K. Morris ◽  
J.D. Tugwood ◽  
C.C. Kirwan

2017 ◽  
Vol 77 (12) ◽  
pp. 1291-1298 ◽  
Author(s):  
Arkadius Polasik ◽  
Marie Tzschaschel ◽  
Fabienne Schochter ◽  
Amelie de Gregorio ◽  
Thomas Friedl ◽  
...  

AbstractDissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called “liquid biopsy”, can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.


2012 ◽  
Vol 13 (7) ◽  
pp. 688-695 ◽  
Author(s):  
Anthony Lucci ◽  
Carolyn S Hall ◽  
Ashutosh K Lodhi ◽  
Anirban Bhattacharyya ◽  
Amber E Anderson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document